IL21 and depressive disorder: IL-21 has been studied regarding its role in response to treatment with the antipsychotic aripiprazole (67), which can also be used as an augmentation strategy in treatment-resistant depression (68), and IL-22 production has been shown to increase during exposure to antidepressants like citalopram or mirtazapine (69).